Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1974-11-18
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-3182
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
38-41
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4605357-Adult,
pubmed-meshheading:4605357-Anxiety Disorders,
pubmed-meshheading:4605357-Clinical Trials as Topic,
pubmed-meshheading:4605357-Depression,
pubmed-meshheading:4605357-Humans,
pubmed-meshheading:4605357-Hydroxyzine,
pubmed-meshheading:4605357-Placebos,
pubmed-meshheading:4605357-Psychiatric Status Rating Scales
|
pubmed:articleTitle |
The use of hydroxyzine (Vistaril) in the treatment of anxiety neurosis.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|